AT293988T
Botulinum toxin pharmaceutical compositions
Abstract
A botulinus with medicine composition, comprising a albumin from blood, does not contain the botulinus device, sodium chloride or the water and polysaccharide for example the ethylol starch and/or the amino acid, the medicine composition is suitable for treating of the medicine to the human patient. A applies the seat; the polysaccharide and amino acid can be reorganized the albumin substituted.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
94 members in 19 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 50014700 | United States of America | A | |
| 0103641 | United States of America | W |
Members94
| Document | Office | Kind | |
|---|---|---|---|
| CA2400318A1 | Canada | A1 | |
| CA2478621A1 | Canada | A1 | |
| CA2494241A1 | Canada | A1 | |
| WO0158472A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU3331501A | Australia | A | |
| WO0158472A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2002064536A1 | United States of America | A1 | |
| KR20020084115A | Republic of Korea | A | |
| EP1253932A2 | European Patent Office (EPO) | A2 | |
| BR0108173A | Brazil | A | |
| CN1398188A | China | A | |
| AR027391A1 | Argentina | A1 | |
| US2003118598A1 | United States of America | A1 | |
| JP2003522154A | Japan | A | |
| US2003138437A1 | United States of America | A1 | |
| US2003138460A1 | United States of America | A1 | |
| EP1398038A1 | European Patent Office (EPO) | A1 | |
| NZ520201A | New Zealand | A | |
| AU2001233315B2 | Australia | B2 | |
| NZ530779A | New Zealand | A | |
| JP2004256545A | Japan | A | |
| MXPA02007519A | Mexico | A | |
| EP1514556A1 | European Patent Office (EPO) | A1 | |
| EP1253932B1 | European Patent Office (EPO) | B1 | |
| AT293988TThis record | Austria | T | |
| ATE293988T1 | Austria | T1 | |
| CN1616084A | China | A | |
| DE60110372D1 | Germany | D1 | |
| CA2400318C | Canada | C | |
| DK1253932T3 | Denmark | T3 | |
| US2005143289A1 | United States of America | A1 | |
| JP2005179375A | Japan | A | |
| PT1253932E | Portugal | E | |
| ES2237551T3 | Spain | T3 | |
| US2005208076A1 | United States of America | A1 | |
| US2005214326A1 | United States of America | A1 | |
| EP1586329A1 | European Patent Office (EPO) | A1 | |
| US2005238663A1 | United States of America | A1 | |
| US2005238664A1 | United States of America | A1 | |
| US2005238667A1 | United States of America | A1 | |
| JP2005336201A | Japan | A | |
| DE60110372T2 | Germany | T2 | |
| KR20060028475A | Republic of Korea | A | |
| US2006099227A1 | United States of America | A1 | |
| US2006104994A1 | United States of America | A1 | |
| CN1258379C | China | C | |
| KR20060090938A | Republic of Korea | A | |
| CA2478621C | Canada | C | |
| US2006269575A1 | United States of America | A1 | |
| KR100665469B1 | Republic of Korea | B1 | |
| EP1398038B1 | European Patent Office (EPO) | B1 | |
| DE60125986D1 | Germany | D1 | |
| PT1398038E | Portugal | E | |
| TW200711657A | Taiwan Province of China | A | |
| DK1398038T3 | Denmark | T3 | |
| US2007081960A1 | United States of America | A1 | |
| ES2275992T3 | Spain | T3 | |
| TWI282739B | Taiwan Province of China | B | |
| CN1331532C | China | C | |
| KR100753765B1 | Republic of Korea | B1 | |
| DE60125986T2 | Germany | T2 | |
| JP2007332155A | Japan | A | |
| KR100799400B1 | Republic of Korea | B1 | |
| US2008108570A1 | United States of America | A1 | |
| JP4118830B2 | Japan | B2 | |
| US2008213315A1 | United States of America | A1 | |
| US7579010B2 | United States of America | B2 | |
| TWI317283B | Taiwan Province of China | B | |
| US2009304748A1 | United States of America | A1 | |
| US7758873B2 | United States of America | B2 | |
| US7780967B2 | United States of America | B2 | |
| EP1398038B2 | European Patent Office (EPO) | B2 | |
| DK1398038T4 | Denmark | T4 | |
| ES2275992T5 | Spain | T5 | |
| CA2494241C | Canada | C | |
| US2011152198A1 | United States of America | A1 | |
| DE60125986T3 | Germany | T3 | |
| EP1514556B1 | European Patent Office (EPO) | B1 | |
| AT519494T | Austria | T | |
| ATE519494T1 | Austria | T1 | |
| PT1514556E | Portugal | E | |
| DK1514556T3 | Denmark | T3 | |
| ES2368061T3 | Spain | T3 | |
| JP2011251988A | Japan | A | |
| JP2012031194A | Japan | A | |
| US8216591B2 | United States of America | B2 | |
| US2012237548A1 | United States of America | A1 | |
| JP5080902B2 | Japan | B2 | |
| US8501196B2 | United States of America | B2 | |
| CY1108007T1 | Cyprus | T1 | |
| US2013296259A1 | United States of America | A1 | |
| US8632785B2 | United States of America | B2 | |
| US2014199288A1 | United States of America | A1 | |
| US9302008B2 | United States of America | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 1905436
Titles2
- German
- PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT BOTULINUM TOXIN
- English
- PHARMACEUTICAL COMPOSITIONS WITH BOTULINUM TOXIN
Classification
- CPC, 10
- A61K9/19
- A61K9/0019
- A61K38/4893
- A61K47/183
- A61K47/36
- A61P21/00
- A61P21/02
- A61P25/00
- A61P25/28
- A61P27/02
- IPC, 23
- A61K35 74
- A61K38 00
- A61K38 16
- A61K38 46
- A61K38 48
- A61K39 08
- A61K45 00
- A61K47 18
- A61K47 36
- A61K47 42
- A61K9 08
- A61K9 14
- A61K9 19
- A61M5 19
- A61M5 24
- A61M5 28
- A61P21 00
- A61P21 02
- A61P25 00
- A61P27 02
- C07K14 195
- C12N9 96
- C12P21 02